Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer
Despite optimal radiation therapy (RT), chemotherapy and/or surgery, a majority of patients with locally advanced non-small cell lung cancer (NSCLC) fail treatment. To identify novel gene targets for improved tumor control, we performed whole genome RNAi screens to identify knockdowns that most repr...
Main Authors: | Cron, Kyle R., Zhu, Kaya, Kushwaha, Deepa S., Hsieh, Grace, Merzon, Dmitry, Rameseder, Jonathan, Chen, Clark C., D'Andrea, Alan D., Kozono, David |
---|---|
Other Authors: | Massachusetts Institute of Technology. Computational and Systems Biology Program |
Format: | Article |
Language: | en_US |
Published: |
Public Library of Science
2013
|
Online Access: | http://hdl.handle.net/1721.1/81218 |
Similar Items
-
HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo.
by: Gupta, A, et al.
Published: (2005) -
Proteasome inhibitors as anti-cancer agents.
by: Murray, R, et al.
Published: (2000) -
The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
by: Cerundolo, V, et al.
Published: (1997) -
Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-kappaB activation.
by: Buchan, A, et al.
Published: (2000) -
Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium Tuberculosis Proteasome
by: Totaro, Kyle A., et al.
Published: (2018)